Lamdong Pharmaceutical Joint Stock Company reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was VND 186,000.72 million compared to VND 187,414.7 million a year ago. Net loss was VND 20,104.87 million compared to VND 38,909.32 million a year ago.

Basic loss per share from continuing operations was VND 1,583 compared to VND 3,063 a year ago. Diluted loss per share from continuing operations was VND 1,583 compared to VND 3,063 a year ago.